Novel Agent Reduces Severe Pruritus in Psoriasis

Share this post

Serlopitant, an oral neurokinin-1 receptor antagonist, blocks the sensation of itch in the brain and reduces pruritus associated with psoriasis, new phase 2 research shows.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply